Home About Us FAQ Policies Contact Site Map

U.S. Markets for Biomaterial Applications of Hyaluronic Acid (HA)

Product Type: Market Research Report Publication Date: Sep 25, 2004
 
Download a sample from "The Infoshop", another service of Global Information.

SUMMARY

Hyaluronic Acid-based Biomaterials Pervade the Healthcare Industry

Hyaluronic acid (HA)-based biomaterials have wide-ranging applications in thehealthcare industry. The materials derived from HA are being used to relieve thepain of knee osteoarthritis, in cataract surgeries, in abdominal and pelvicsurgeries, and as a dermal filler to erase facial wrinkles. Moreover, an agingpopulation, several product innovations, and underserved end-user segments arecreating a huge market for HA-based biomaterials. Some existing end usersinclude rheumatologists, ophthalmologists, plastic and reconstructive surgeons,anti-adhesive wound care specialists, and gynecologists.

This Frost & Sullivan strategic analysis service provides an overview ofand an outlook for the U.S. biomaterial applications of hyaluronic acid. Thestudy is segmented into viscosupplementation products for osteoarthritis,viscoelastic products for ophthalmic applications, facial aesthetic implants,and post-surgical anti-adhesion barriers. It enables the development of growthstrategies to enhance companies\' market shares and revenue.

HA-based Biomaterials Need a Dose of Innovation to Stay Ahead

Many market segments where HA-based biomaterials have become firmlyentrenched are facing increasing reimbursement pressure from Medicare and otherhealthcare providers. An example is the lower reimbursements for physicians forcataract surgeries, who, in turn, want reduced prices for HA-based viscoelastics.Medicare is also cutting reimbursements of viscosupplementation procedures usingHA-based material for knee osteoarthritis. These market segments have not seensignificant recent innovation with HA-based biomaterials. The market also needsto fight price erosion by adding value to its products.

Some market participants are already planning to develop the next generationof viscosupplements as good carriers for drug delivery. Medical devicemanufacturers can also fund research to unravel the mechanism ofviscosupplements. "Once this is done, it will boost physician confidenceleading to increased use of this procedure," says the analyst. Productmanufacturers and marketers are also likely to ensure that their productsmaintain the value-to-price ratio in order to gain wide customer appeal.

Demand Expected to be Buoyed by Aging Baby Boomers

The number of people above 65 years is expected to more than double from 35million in 2000 to 71 million in 2020 in the United States. People in this agegroup will be entering a stage where the incidence of osteoarthritis, cataract,and facial wrinkles increases. HA-based biomaterials have a significant role toplay in the treatment of all these afflictions. Thus, the demand for HA-basedbiomaterials is expected to be spurred by the aging demographics.

Since the knee osteoarthritis patient population is expected to increase by26 percent from 15 million in 2000 to 19 million in 2010, viscosupplements canexpect an escalation in demand. Apart from a huge market for osteoarthritismedication, the post-surgical anti-adhesion barrier market also carries a hugepotential. Internal adhesions after abdominal surgeries can cause problems, suchas bowel obstruction and pain. "Due to the critical nature of thesecomplications, surgeons are demanding anti-adhesion barriers that performconsistently," notes the analyst. Adhesion lysis surgeries are performedmore frequently on those above 65 years than on younger age groups.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and newtheories tested in hundreds of companies across many industries, Frost &Sullivan has evolved its Growth Partnership Services (GPS) program that providesestablished and emerging firms with powerful growth visions. Moving beyond tokenmission statements, GPS provides an actionable vision to growth consultingpartners by illustrating how key intelligence and strategic research based ondefined goals can guide day-to-day behavior and overall company direction. Thefoundation of Frost & Sullivan's GPS includes:

  • Assisting companies to reach their full potential in the core business
  • Providing growth strategies to help companies expand into relatedbusinesses
  • Preemptively redefining the core business during market turbulence
  • Applying the Frost & Sullivan framework to identify and address commonmistakes resulting from misaligned corporate strategies
  • Recommending growth management strategies through continuous partnership

To maximize the potential for growth within a firm\'s internal and externalenvironment, Frost & Sullivan consultants can facilitate the creation ofstrategic programs that deliver improved market success. Frost &Sullivan\'s strengths lie in combining strategic understanding with marketexpertise and applying these with absolute commitment to its clients\' growth.

TABLE OF CONTENTS

1 TOTAL HYALURONIC ACID-BASED BIOMATERIALS MARKETS

  • Executive Summary and Overview
    • Executive Summary
    • Overview
    • Major Participants in this Industry
  • Research Segmentation
    • Segmentation by Product
    • Segmentation by End User
  • Forecasts and Trends
    • Market Drivers
    • Market Challenges
    • Revenue Forecasts
  • Frost & Sullivan Market Engineering Awards
    • Frost & Sullivan Award for Product Differentiation Innovation
    • Frost & Sullivan Award for Entrepreneurial Company
    • Frost & Sullivan Award for Product Line Strategy
    • Frost & Sullivan Award for Competitive Strategy Leadership

2 OSTEOARTHRITIS VISCOSUPPLEMENTATION PRODUCTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Osteoarthritis Viscosupplementation Forecasts and Trends
    • Assumptions
    • Procedure Forecast
    • Pricing Forecast
    • Revenue Forecast
  • Osteoarthritis Viscosupplementation Competitive Analysis
    • Market Share Analysis
    • Genzyme and Wyeth Partnership
    • Fidia and Sanofi-Synthelabo Partnership
    • Seikagaku and Smith & Nephew Partnership
    • Anika Therapeutics and Ortho Biotech Partnership

3 OPHTHALMIC VISCOELASTIC PRODUCTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Opthalmic Viscoelastics Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Ophthalmic Viscoelastics Competitive Analysis
    • Market Share Analysis
    • Alcon
    • Advanced Medical Optics (AMO)
    • Bausch & Lomb

4 FACIAL AESTHETIC IMPLANTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Facial Aesthetics Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Facial Aesthetics Competitive Analysis
    • Market Share Analysis
    • Inamed Corporation
    • Medicis Pharmaceutical Corporation

5 POST-SURGICAL ANTI-ADHESION BARRIERS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Competitive Analysis
    • Market Share Analysis
    • Genzyme

6 DECISION SUPPORT TABLES

  • Statistics on Asian Countries
    • Australia
    • China
    • India
    • Japan
    • South Korea

U.S. Markets for Biomaterial Applications of Hyaluronic Acid (HA)

Publisher: Frost & Sullivan

Format Price Order
Web Access US $3950.00
Hard Copy & Web Access (Regional License) US $4450.00
All orders are processed by "www.the-infoshop.com". www.the-infoshop.com is another Global Information web site. This transfer is entirely safe.
Copyright© 2008 GII - All Rights Reserved.